Founded in 1994 and listed on the Shanghai Stock Exchange in August 1998, Shanghai Fosun Pharmaceuticals (Group) Co., Ltd. (“Fosun Pharma”) is China’s leading healthcare industry group. Fosun Pharmaceutical Group to promote human health as the mission, business coverage of the entire pharmaceutical health industry chain. Looking to the future, Fosun Pharma will be adhering […]
From April 13, 2020, the Penguin Almond Group Xi’an Surgery Center will also become the eighth day surgical centre of the Penguin Almond Group (Tencent) after Shenyang, Shenzhen, Chengdu, Guangzhou, Shanghai, Nanjing. The day surgical centre signed a contract to reach strategic cooperation with Micurae, filling the gap in the group’s northwestern region. Xi’an Surgery […]
Micurae, as a leading Australian Medical Consultative Company, was invited to present our cloud based international second opinion platform and end-to-end Tele-health capabilities. It was a fantastic opportunity to showcase our products and services to a wonderful array of industry leaders, organisations and experts.
Micurae has been chosen as a Preferred Business Partner by Medibank Australia. This further strengthen our ability to provide comprehensive, streamlined services to our new and pre-existing clients. Together with Medibank’s bespoke coverage, we are confident the help is there wherever, whenever.